We developed a new quantitative system for diagnosis of invasive pulmonary aspergillosis (IPA) using realtime automated polymerase chain reaction (PCR). Intra-assay and interassay precision rates for in vitro examination were 2.53% and 2.20%, respectively, and the linearity of this assay was obtained when there were 120 copies/well. We examined 323 samples taken from 122 patients with hematological malignancies, including 33 patients with IPA and 89 control patients. Blood samples were subjected to PCR antigen detection methods, using enzyme-linked immunosorbent assay (ELISA) and determination of plasma (1r3)-b-D-glucan (BDG) concentration. The sensitivities of PCR, ELISA, and BDG measurement for diagnosis of IPA were 79%, 58%, and 67%, respectively; the specificities were 92%, 97%, and 84%. Positive findings on PCR preceded those of computed tomography by days, those of BDG measurement by days, and those of ELISA Ϫ0.3 ‫ע‬ 6.6 6.5 ‫ע‬ 4.9 by days. Real-time PCR was sensitive for IPA diagnosis, and quantitation was accurate.
Invasive pulmonary aspergillosis (IPA) is a fatal complication in immunocompromised hosts who undergo intensive cytotoxic chemotherapies. The survival of these patients depends on early diagnosis and prompt initiation of therapeutic measures [1] , but mycological and histopathological diagnosis is rarely established, because blood culture is not sufficiently sensitive for this disease [2] , and invasive procedures are necessary to obtain pathological evidence. The difficulty of making an early diagnosis of IPA is a critical problem. Efforts have been made, therefore, to develop reliable noninvasive diagnostic techniques.
Use of CT of the chest and antigen-detection methods have been advocated for early diagnosis of IPA. The most characteristic findings of CT in IPA are a halo of ground-glass attenuation around focal nodules and aircrescent formation [3] . Both signs are relatively specific to IPA in febrile neutropenic patients, but they have also been reported in association with a variety of other diseases [4] . Thus, it is impossible to establish a definite diagnosis of IPA on the basis of the findings of CT scans of the chest. Detection of circulating Aspergillus or fungal antigens is another useful method for the diagnosis of IPA. Currently, 3 methods are used: the latex agglutination test, ELISA, and measurement of the plasma (1r3)-b-d-glucan (BDG) concentration. The latex agglutination test and ELISA are commercially available for use in detecting circulating galactomannan antigen. BDG is a ubiquitous component of fungi [5] , and the determination of its plasma concentration is another useful screening method for deep mycosis, including IPA [6] . The BDG assay is widely used in Japan. Because these blood tests detect circulating fungal components, their specificities are as high as 90% [6] [7] [8] . However, these tests yield positive results only at ad- 8 copies/well (black bar) of standard Aspergillus DNA were amplified in duplicate for 50 cycles. The normalized reporter (Rn) value was calculated by dividing the emission intensity of the reporter dye by the emission intensity of the reference dye included in the TaqMan Universal PCR Master Mix, which does not participate in the exonuclease-based PCR assay. DRn is the difference between the Rnϩ value and the RnϪ value, where Rnϩ is the Rn value of a reaction that contains all components, including the template, and RnϪ is the Rn value obtained from early cycles, before a detectable increase in fluorescence, during real-time PCR.
vanced stages of infection in a majority of patients with IPA, which is a critical problem [9, 10] .
PCR may be useful for the detection of fungal nucleic acids because it can be more sensitive than the current antigen detection methods. Numerous protocols have been established for the diagnosis of Aspergillus infection by use of PCR [11] [12] [13] , and they have been successfully used to detect Aspergillus DNA in bronchoalveolar lavage fluid [14] and in serum obtained from patients with IPA [12] . Although the conventional PCR assay is highly sensitive, with a detection limit of 10 fg of Aspergillus-specific DNA [12] , it does not provide quantitative information on the fungal burden. Such information is a requisite for the management of IPA. Real-time PCR is a quantitative assay reported by Heid et al. in 1996 [15] . This method measures PCR product accumulation through a dual-labeled fluorogenic probe (TaqMan Probe) and provides accurate and reproducible quantitation of gene copies [15] . We recently developed a new quantitative diagnostic system using this exonuclease-based PCR assay as a rapid alternative to conventional PCR for the diagnosis of IPA. This is the first report on the use of quantitative real-time PCR for the diagnosis of IPA.
MATERIALS AND METHODS
Extraction of DNA from blood samples. Fungal DNA was extracted from 200 mL of whole blood or plasma in a biosafety hood in a separate room provided with equipment exclusively used for DNA extraction [16] . The procedures used for DNA extraction have been reported elsewhere [17] . To avoid contamination, amplicons were never processed in this area.
Blood samples were stored at Ϫ80ЊC and thawed to 4ЊC before testing. Freeze/thaw cycles were not repeated, and we used newly thawed samples in this study. Our preliminary study showed that sensitivity of PCR increased as the blood volumes increased (data not shown) and, therefore, that it is preferable to use 15 mL of blood for PCR samples. However, we used 200 mL of blood or plasma for PCR samples, because the volume of most stored samples was 200-500 mL.
Amplification and detection of Aspergillus DNA. Sequences of PCR primers and probes were selected on the basis of the sequences of fungal 18S rRNA genes in the GenBank database. The primers and probes hybridized a consensus sequence for Aspergillus species. The forward primer was 5 -TTG-GTGGAGTGATTTGTCTGCT-3 , and the reverse primer was 5 -TCTAAGGGCATCACAGACCTG-3 . The TaqMan probe selected the region between the primers, which was fluorescencelabeled with FAM (6-carboxy-fluorescein) at the 5 end as the reporter dye and TAMRA (6-carboxy-teremethyl-rhodamine) at the 3 end as the quencher (FAM-TCGGCCCTTAAATAGC-CCGGTCCGC-TAMRA). The primers and the TaqMan probe were obtained from FASMAC.
Procedures for PCR and detection of the PCR product have been reported elsewhere [17] . DNA from an Aspergillus fumigatus isolate was amplified with both primers and inserted into pCR2.1 TA Cloning vector (Invitrogen). We used this plasmid as the standard in this study.
Quantitation of Aspergillus DNA was performed with a serially diluted standard in the range of -copies/ 1 8 1 ϫ 10 1 ϫ 10 well, and the copy numbers of Aspergillus species were calculated by Sequence Detection System v. 1.6.3. software (PE Biosystems). Fluorescence intensity was measured in each well every 7 s, and the result was deemed to be positive when the fluorescence intensity exceeded 10 times the baseline fluorescence (figure 1). The threshold cycle value was defined as the PCR cycle number at that point.
In vitro examination of sensitivity and specificity of realtime automated PCR. To determine the sensitivity of realtime automated PCR for detection of Aspergillus, 100 copies/ mL of standard DNA were serially diluted with TE buffer (10 mM Tris-HCl [pH 8.0] and 1 mM EDTA). The diluted DNA samples were measured 5 times.
To determine the specificity, DNA from A. fumigatus, Aspergillus niger, Aspergillus terreus, Candida albicans, Candida tropicalis, Candida krusei, Candida parapsilosis, Candida glabrata, and Candida guilliermondii isolates was subjected to realtime PCR.
In vivo comparison of real-time PCR with ELISA and BDG measurement. To compare the sensitivity and specificity of real-time PCR with those of other blood tests for the diagnosis of IPA, we investigated blood samples obtained from patients in our hematology wards who underwent chemotherapy as treatment for hematological malignancies or severe aplastic anemia.
All the blood samples were subjected to real-time PCR, ELISA (Platelia Aspergillus; Diagnostic Pasteur), and BDG determination (Fungi-Tec; Seikagaku Corporation). These tests were performed as described elsewhere [5, 18] . When an optical density ratio of ELISA 11.5 was observed in at least 2 samples, we classified the ELISA results for those patients as positive. The cutoff level for the BDG measurement was 20 pg/mL [6] . When these tests were performed more than once, the highest value in each febrile episode was used in the analysis of data.
Conditions of hospitalization. All patients who underwent bone marrow transplantation (BMT) and some patients who were receiving high-dose chemotherapy were cared for in protective isolation in rooms equipped with high-efficiency particulate air filters throughout the period of neutropenia. All the patients received either fluconazole (200 or 400 mg/day) or itraconazole (200 mg/day) as antifungal prophylaxis. We managed neutropenic fever according to procedures described in the report by Pizzo [19] .
Blood sampling, chest CT scanning, and fungal cultures. From August 1996 through March 1999, blood samples were stored when we suspected, on the basis of clinical and radiological findings, that patient had IPA. From April 1999 through April 2000, we prospectively examined patients who had antibiotic-resistant fever. Blood samples were drawn weekly and subjected to ELISA, BDG assay, and PCR. Cultures were performed on samples from the throat, urine, feces, blood, and sputum when antibiotic-resistant fever developed. We performed chest CT scans when patients had any signs of pulmonary infection or of antibiotic-resistant fever. Patients with conditiona that required chest CT have been reported elsewhere [20] . Bronchoalveolar lavage is not usually performed in our institutions if patients have either thrombocytopenia or neutropenia.
Diagnostic criteria for IPA. We made a diagnosis of definite IPA when patients had histological evidence of tissue invasion by branched septate hyphae, when a patient's condition did not respond to antibacterial agents, and when testing of sputum samples or biopsy specimens or autopsy results were positive for Aspergillus species. We classified patients who developed fever but showed no signs of IPA as control patients. Patients who were suspected of having IPA on the basis of radiological findings [3] but who had no histological evidence of IPA were excluded from this study.
Statistical analyses. Data were analyzed for statistical significance by the 2-tailed Fisher exact test or by the x 2 test. Correlation analysis was performed using Kendall's nonparametric correlation coefficient. The level of statistical significance was set at . P ! .05
RESULTS
In vitro sensitivity, reproducibility, and specificity of real-time PCR. Copy numbers of Aspergillus DNA and threshold cycle values of the serially diluted standard were plotted on the Xaxis and the Y-axis, respectively, of the graph shown in figure  2 . The correlation coefficient was .988. The intra-assay coefficient of variance (CV) was !5% (0.83%-4.7%) between 20 and 10 10 copies/well and 12.8% at 10 copies/well. Although we could detect as few as 10 copies/well, the sensitivity of realtime PCR as a quantitative assay was reduced to 20 copies/well. When we measured samples that contained 10 
n p 5 n p 2 and adrenal gland ( ). Aspergillus involvement was limited n p 2 to the lung in 16 patients, and systemic dissemination was observed in the other 17 patients. Complications in the control group were septicemia due to C. tropicalis ( ), septicemia n p 2 due to C. glabrata ( ), pneumonia due to C. albicans n p 2 ( ), pneumonia due to C. tropicalis ( ), cytomega- graft-versus-host disease ( ), progression of hematological n p 7 malignancy ( ), and fever of unknown origin ( ). n p 13 n p 6 Results of real-time PCR, ELISA, and BDG measurement. We obtained 102 blood samples, including 92 whole blood and 10 plasma samples, from the 33 patients with IPA, and 221 samples, including 198 whole blood and 23 plasma samples, from the 89 control patients. We did not divide blood samples into whole blood and plasma to investigate which of the 2 samples was more suitable for use in PCR for detection of fungal DNA. On average, 3.1 (range, 1-8) and 2.5 (range, 1-7) samples were drawn from patients in the IPA group and in the control group, respectively. Table 2 shows the results of these tests in each patient with IPA.
Of the 33 patients with IPA, 26, 19, and 22 had positive results of PCR, ELISA, and BDG measurement, respectively, and 7, 3, and 14 of the 89 control patients had positive results of these assays. The sensitivities of real-time PCR, ELISA, and BDG measurement were 79%, 58%, and 67%, respectively. The specificities of the assays were 92%, 97%, and 84%. The positive predictive values were 79%, 86%, and 61%, respectively, and the negative predictive values were 92%, 86%, and 87%.
Of the 102 samples obtained from the 33 patients with IPA, 34 were drawn before empirical treatment with amphotericin B was started or in patients who were not receiving itraconazole prophylaxis. Fungal DNA was found, using PCR, in 12 of the 34 samples. Sixty-eight samples were collected after initiation of empirical amphotericin B treatment or during prophylactic administration of itraconazole. Fungal DNA was found, using PCR, in 20 of those 68 samples. Neither amphotericin B nor itraconazole administration seemed to influence the PCR results ( ). P p .6516 Results of fungal culture and CT scanning. Chest CT scans were performed on all 33 patients with IPA. All of the patients showed some abnormal findings in CT scans. The most common CT sign was multiple nodular consolidations. Either halo or air-crescent signs were observed in 12 patients with IPA. No control patients showed these signs.
All of the patients with IPA had microbiological evidence of Aspergillus infection. The organism was isolated from culture of samples obtained before death from 13 patients. Twelve cultures were of sputum samples, and 1 was of a biopsy specimen from the lung. Aspergillus infection was identified after the patient's death in the remaining 20 patients. The causative Aspergillus species were A. fumigatus ( ) ,A. flavus ( ), n p 20 n p 4 A. niger ( ), and Aspergillus species that were not subn p 2 classified ( ). n p 6 We show the association between PCR and other examinations in table 3. A significant association between PCR and the other examinations was not observed.
Interval between onset of fever and day on which each test yielded positive results. After retrospective study of 18 patients, we prospectively evaluated 15 patients who had IPA. For these patients, CT scans, PCR, BDG measurement, and ELISA yielded results that supported a diagnosis of IPA at a mean (‫ע‬SD) of , , , and 11.2 ‫ע‬ 3.5 11.1 ‫ע‬ 5.7 15.5 ‫ע‬ 8. 4 17.2 ‫ע‬ 10.2 days after the onset of fever, respectively. Positive findings of PCR preceded those of CT scan by days, those of Ϫ0.3 ‫ע‬ 6.6 the BDG assay by a mean (‫ע‬SD) of days and pre-6.5 ‫ע‬ 4.9 ceded those of ELISA by a mean of days (table 2) . 2.8 ‫ע‬ 4.1 Typical clinical course. Figure 3 illustrates the clinical course of a patient who developed IPA with tracheobronchial involvement (patient 9, table 2) [21] . The patient died of respiratory failure caused by Aspergillus tracheobronchitis. ELISA, BDG measurement, and real-time PCR yielded positive results on days 165, 169, and 161 after transplantation, respectively. Real-time PCR yielded positive results earlier than did BDG assay and ELISA and reflected the response to antifungal treatment with greater sensitivity.
DISCUSSION
We developed a new method for the diagnosis of IPA, real-time PCR for use with blood samples. This method has some advantages over antigen-detection tests and conventional PCR assays.
First, real-time PCR is sensitive for IPA diagnosis. Although PCR that uses blood samples has not been successfully applied to IPA diagnosis [22] , Aspergillus DNA was detected in 26 of 33 IPA patients in our study. The sensitivity of real-time PCR (79%) was higher than that of ELISA (58%) and that of BDG measurement (67%) and was comparable to that reported for nested PCR [23] . Although the detection limit of real-time PCR, 20 copies/mL, may be insensitive compared with that of conventional PCR [12] , we can accurately quantitate 20 copies of Aspergillus-specific DNA using this PCR method and can detect !10 DNA copies. Considering the quantitative ability of this assay, we defined 20 copies as its threshold.
It may be important that we extracted Aspergillus DNA from the blood without removal of fungal cell walls by mechanical disruption or enzymatic treatment. These steps are considered to be essential for DNA extraction from fungi. However, Aspergillus DNA might circulate in the blood as naked DNA or in combination with damaged cell walls. Quantitation of these DNA might be promising for fungal PCR. It is interesting that neither PCR nor the antigen detection tests uniformly had positive results more often in our study (table 3) . Because the 3 assays recognize different fungal components, the combined use of these tests will improve the rate of detection of Aspergillus infection.
Second, real-time PCR is highly specific for Aspergillus infection. No Candida species DNA was amplified during in vitro examination, and real-time PCR yielded negative results for patients who had invasive candidiasis, Pneumocystis carinii pneumonia, and viral infections.
Third, real-time PCR seems to be an accurate method of quantitating fungal copies. In vitro examination showed that the CV of real-time PCR was !5% for 10 Aspergillus copies and increased to 12.8% when the number of copies was 10. Furthermore, maximum levels (in copies/mL) for PCR correlated well with those for ELISA and BDG measurement in a clinical setting (table 2). Figure 3 illustrates the clinical course of a patient who developed IPA after BMT. The number of copies found by PCR correlated well with the optical density of ELISA and levels of BDG. Real-time PCR yielded positive results earlier than the other methods and reflected the disease progress with greater sensitivity.
Real-time PCR is a promising method for use in diagnosis of IPA, but we have to comment on contamination. In Aspergillus PCR, contamination occurs by airborne spore inoculation during the procedures, by product carryover, and because of the presence of fungal spores in PCR materials. In this study, none of the control reagents had results that were positive for Aspergillus DNA, which implies that environmental contamination was negligible. Another possible cause of contamination is carryover of PCR products. PCR amplicons may serve as targets for further reactions. To avoid the carryover of amplicons, we treated PCR samples with uracil-DNA-glycosylase digestion, which has been proved elsewhere to inactivate amplicons from PCR products [24] . The other possibility is contamination of commercially available products used for PCR. These materials could be carriers of fungal spores, and many companies seem not to be aware of the fact that their products might be used for fungal PCR [25] . We also experienced such contamination of PCR reagents during the development of real-time PCR and therefore made it a rule to examine the contamination of reagents before PCR assays. Thereafter, the problem of reagent contamination disappeared.
Real-time PCR is definitely useful for IPA diagnosis, but our study has several limitations that need to be discussed. Of most importance was the finding that real-time PCR produced falsepositive results more frequently than the other tests in this study. Although the in vitro study showed that real-time PCR was highly specific for Aspergillus species, 7 (7.8%) of 89 control patients had positive results at some point during the clinical course of their illnesses. We cannot deny the possibility that contamination was the cause of these false-positive results, but Aspergillus-specific DNA might have existed in these samples. We have reported elsewhere that the Aspergillus latex agglutination test occasionally yielded positive results in the case of neutropenic patients without IPA [10] . We discussed the possibility that some fungal components circulated in the peripheral blood of these patients and that the components were cleared with neutrophil recovery. Positive results of PCR do not necessarily indicate the presence of IPA. Real-time PCR may be helpful in differentiating true IPA from transient Aspergillus antigenemia, because it can provide quantitative information on the fungal burden.
Furthermore, we cannot make a definite conclusion concerning the timing of positive tests from our study. We prospectively evaluated only 15 patients with IPA. Positive findings of PCR preceded those of CT scan by a mean (‫ע‬SD) of Ϫ0.3 ‫ע‬ 6.6 days, those of the BDG assay by a mean of days, and 6.5 ‫ע‬ 4.9 those of ELISA by a mean of days (table 2) . PCR 2.8 ‫ע‬ 4.1 seemed to be almost as sensitive as chest CT scan for diagnosis of IPA. How early in the clinical course PCR yields positive results for patients with IPA is an area that needs further evaluation. In conclusion, we have developed a real-time PCR for use in the diagnosis of IPA that is highly sensitive and allows us to accurately quantitate circulating copies of Aspergillus DNA.
